|
|||||
|
|
The Hepatocarcinoma Cell Line HepG2 Does Not Express a GHS-R1a-Type Ghrelin Receptor |
|
| Authors: | LEEN THIELEMANS PIETER J. PEETERS HEIDI JONCKHEERE WALTER LUYTEN RONALD DE HOOGT BERNARD COULIE |
| Affiliation: | 1. Department of Internal Medicine, Johnson &2. Johnson Pharmaceutical Research &3. Development, a division of Janssen Pharmaceutica NV, Beerse, Belgium;4. IriDM Corporation, Leuven, Belgium |
| Abstract: | |
| Keywords: | HepG2 Ghrelin Receptor GHS-R1a GPCR |